Although I wouldn’t mind seeing the Lions select an offensive lineman here, I’m going to go with an EDGE defender. And I believe that Detroit should target one of two guys: Georgia’s Mykel Williams or ...

Tomorrow, dear reader, is the first day of the Battle of Ontario. It's the Toronto Maple Leafs and Ottawa Senators in just ...

Many have built campaigns on a promise to make New York more affordable, with child care as a centerpiece. By Eliza Shapiro By the time Rebecca Bailin reached her mid-30s, she had grown tired of ...

Olympic champion Shelly-Ann Fraser-Pryce had an obvious advantage over the other parents at her son's school sports day but that didn't prompt her to go easy on the field. The Jamaican athlete ...

“If we can keep the core of the team, it will already be a big ... This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability ...

Bitcoin's censorship-resistant, decentralized setup empowers individuals by facilitating peer-to-peer transactions without government interference or corporate control. You’ve probably heard ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

When you buy through links on our articles, Future and its syndication partners may earn a commission. The highly-rated Disney+ TV show, which mostly thrilled us during its first season, will be ...

The FDA has approved Novo Nordisk’s Xultophy and Sanofi’s Soliqua on the same day, pitching the rival diabetes combination into head-to-head competition. Both products combine a long acting ...